Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

ASTROTECH Corp ASTC

· Healthcare · Laboratory Analytical Instruments

FY2025 10-K, filed 2025-09-26
SEC EDGAR

Filing evidence summary

Caution evidenceCoverage 4/5 core metrics

Latest reported annual revenue changed -37.0% from the prior reported annual observation.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Revenue contracted

    Latest reported annual revenue changed -37.0% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-06-30.

  • Operating margin compressed

    Operating margin changed -606.5 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-06-30.

  • Free cash flow was negative

    Latest reported free cash flow was -$14M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-06-30.

  • 4 filing risk checks flagged

    Flagged areas: Earnings quality, Solvency & liquidity, Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

Core trend metrics

Latest annual revenue growth
-37.0%
as of 2025-06-30
Latest annual operating margin
-1404.6%
as of 2025-06-30
Free cash flow
-$14M
as of 2025-06-30
ROIC snapshot
-95.8%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

4of 10 rule-based checks flagged
  • Earnings quality
  • Solvency & liquidity
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-06-30
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-06-3010-K filed 2025-09-26prior period 2024-06-30 from the same filingView filing
By product or service
Revenue
  • Product$804K
    76.6%
    -49.0% yoy
  • Service$130K
    12.4%
    +47.7% yoy
  • Grant$115K
    11.0%
    no prior

Members sum to the consolidated $1.05M for this period.

By geography
Revenue
  • United States$730K
    69.6%
    no prior
  • Outside the United States$319K
    30.4%
    -80.8% yoy

Members sum to the consolidated $1.05M for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-13prior period 2025-12-31 from the same filingView filing
  • Service$217K
    63.3%
    no prior
  • Product$147K
    42.9%
    no prior
  • Grant-$41K
    -12.0%
    no prior
  • Warranty$20K
    5.8%
    no prior
  • Training$0
    0.0%
    no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-06-30 · among 4,122 US-listed filers · 318 in Healthcare
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$1M
4thof 3,301
bottom third
5thof 291
bottom third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
-37.0%
4thof 3,135
bottom third
2ndof 277
bottom third
Gross margin
gross profit ÷ revenue
45.3%
60thof 1,603
middle third
31stof 212
bottom third
Operating margin
operating income ÷ revenue
-1404.6%
6thof 2,819
bottom third
6thof 280
bottom third
Net margin
net income ÷ revenue
-1320.3%
5thof 3,263
bottom third
5thof 290
bottom third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
-1314.1%
4thof 2,679
bottom third
4thof 261
bottom third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-62.7%
16thof 3,577
bottom third
28thof 291
bottom third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
79.1%
8thof 2,895
bottom third
6thof 272
bottom third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
169 days
4thof 2,398
bottom third
1stof 266
bottom third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-2.8%
37thof 3,577
middle third
23rdof 272
bottom third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-06-30 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-2.8%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 4
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 0 changed periods

No period on file has changed between its first report and the latest filing carrying it.

3 share-count periods re-presented for a stock split (1-for-30) are listed apart from restatements and not counted above.

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest annual report10-K FY2025 · filed 20250926View filing
Commitments and contingencies · 1,128 characters as filed

( 13 ) Commitments and Contingencies Legal Proceedings From time to time, the Company is subject to legal and administrative proceedings, settlements, investigations, claims and actions. The Companys assessment of the likely outcome of litigation matters is based on its judgment of a number of factors including experience with similar matters, past history, precedents, relevant financial and other evidence and facts specific to the matter. Notwithstanding the uncertainty as to the final outcome, based upon the information currently available, management does not believe any matters, individually or in aggregate, will have a material adverse effect on the Companys financial position or results of operations. The Company establishes reserves for the estimated losses on specific contingent liabilities, for regulatory and legal actions where the Company deems a loss to be probable and the amount of the loss can be reasonably estimated. In other instances, the Company is not able to make a reasonable estimate of liability because of the uncertainties related to the outcome or the amount or range of potential loss.

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

Employee benefit plans · 550 characters as filed

( 12 ) Employee Benefit Plans Astrotech has a defined contribution retirement plan, which covers substantially all employees and officers. `For the years ended June 30, 2025 and 2024 , the Company made matching contributions of $92 thousand and $82 thousand, respectively, to the plan. The Company has the right, but not an obligation, to make additional contributions to the plan in future years at the discretion of the Companys Board of Directors. The Company has not made any additional contributions for the years ended June 30, 2025 and 2024 .

CompensationAndEmployeeBenefitPlansTextBlock · excerpt; the full note is in the filing

Revenue disaggregation · 145 characters as filed

(In thousands) June 30, 2025 June 30, 2024 Product Revenue $ 804 $ 1,576 Grant Revenue 115 - Service Revenue 130 88 Total Revenue $ 1,049 $ 1,664

DisaggregationOfRevenueTableTextBlock

Share-based compensation · 4,277 characters as filed

( 9 ) Common Stock Incentive, Stock Purchase Plans, and Other Compensation Plans Stock Option Activity Summary The Companys stock option activity for the years ended June 30, 2025 and 2024 was as follows: Weighted Shares Average Exercise Price Outstanding at June 30, 2023 38,166 $ 27.34 Granted 131,840 10.01 Exercised - - Canceled or expired (13,378 ) 10.70 Outstanding at June 30, 2024 156,628 $ 14.18 Granted 102,260 9.43 Exercised - - Canceled or expired (45,775 ) 12.10 Outstanding at June 30, 2025 213,113 $ 12.35 The aggregate intrinsic value of options exercisable at June 30, 2025 was $0 as the fair value of the Companys common stock is less than the exercise prices of these options. The aggregate intrinsic value of all options outstanding at June 30, 2025 was $3 thousand. Options Outstanding Options Weighted- Exercisable Average Weighted- Weighted- Number Remaining Average Number Average Outstanding Contractual Exercise Exercisable Exercise Range of exercise prices Life (years) Price Price $5.50 $9.69 55,000 9.45 $ 7.41 2,551 $ 9.21 $10.10 $11.27 79,770 8.24 10.12 27,720 10.14 $11.51 $19.20 76,402 8.22 14.21 29,422 18.42 $159.00 $175.50 1,941 1.86 170.33 1,941 170.33 $5.50 $175.50 213,113 8.49 $ 12.35 61,634 $ 19.10 Compensation costs recognized related to vested stock option awards during the years ended June 30, 2025 and 2024 were $622 thousand and $480 thousand, respectively. At June 30, 2025 , there was $858 thousand of total unrecognized compensation cost related to

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

Fair value · 2,162 characters as filed

( 6 ) Fair Value Measurement ASC Topic 820 Fair Value Measurement (Topic 820 ) defines fair value, establishes a market-based framework or hierarchy for measuring fair value, and expands disclosures about fair value measurements. Topic 820 is applicable whenever assets and liabilities are measured and included in the financial statements at fair value. The fair value hierarchy established in the standard prioritizes the inputs used in valuation techniques into three levels as follows: Level 1 - Quoted prices in active markets for identical assets or liabilities. Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 - Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. The following tables present the carrying amounts, estimated fair values, and valuation input levels of certain financial instruments as of June 30, 2025 , and June 30, 2024 : June 30, 2025 Carrying Fair Value Measured Using Fair (In thousands) Amount Level 1 Level 2 Level 3 Value Available-for-Sale Securities Short-Term Investments Mutual Funds - Corporate & Government Debt $ 9,879 $ 9,879 $ - $ - $ 9,879 ETFs - Corporate & Governm

FairValueDisclosuresTextBlock · excerpt; the full note is in the filing

Income taxes · 7,343 characters as filed

( 10 ) Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are more likely than not to be realized. As of June 30, 2025, and 2024, the Company had established a full valuation allowance against all of its net deferred tax assets. For the fiscal years ended June 30, 2025, and 2024, the Company incurred losses from operations in the amount of $13.8 million and $11.7 million, respectively. The effective tax rate for the fiscal years 2025 and 2024 was 0.01% and 0.01%, respectively. There is materially no current state tax expense. FASB ASC 740, Income Taxes addresses the accounting for uncertainty in income taxes recognized in an entitys financial statements and prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken or expected to be taken on a tax return. The Company had unrecognized tax benefit of $762 thousand as of June 30, 2025, all of which has been accounted for as contra deferred tax assets. For the years ended June 30, 2025, and 2024, the Companys effective tax rate differed from the federal statutory rate of 21%, primarily due to tax credits and the valuation allowance against its net defer

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 6,448 characters as filed

"Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) No. 2023 - 07, Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, with retrospective application to all prior periods presented. We adopted this standard in fiscal year 2025. The adoption of this on July 1, 2024 did not have a material impact on its financial statements. In November 2023, the FASB issued Accounting Standards Update 2023 - 07 Segment Reporting (Topic 280 ): Improvements to Reportable Segment Disclosures. All public entities will be required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. We adopted this standard in fiscal year 2025. The Company implemented enhanced annual segment reporting disclosures based on new requirements. ASU 2022 - 04 - Supplier Finance Program (SFP) . This ASU requires that a buyer in an SFP disclose qualitative and quantitative information about its program, including the nature of the SFP and key terms, outstanding amounts as of the end of the reporting period, and presentation in its financial statements. This pronouncement has not impacted the Companys consolidated financial statements. In August 2020, the FASB issued ASU No. 2020

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Significant accounting policies · 33,654 characters as filed

"( 2 ) Summary of Significant Accounting Policies Principles of Consolidation and Basis of Presentation The preparation of these consolidated financial statements in conformity to U.S. Generally Accepted Accounting Principles (GAAP) for the accounts of Astrotech Corporation and all its wholly owned subsidiaries requires management to make judgments and estimates and form assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and underlying assumptions are reviewed on an ongoing basis. Actual outcomes may differ from these estimates under different assumptions and conditions. All intercompany transactions have been eliminated in consolidation. Certain prior year amounts have been reclassified to conform to the current year presentation and have had no impact on net income or stockholders' equity. Revenue Recognition Astrotech recognizes revenue employing the generally accepted revenue recognition methodologies described under the provisions of Accounting Standards Codification (""ASC"") Topic 606 Revenue from Contracts with Customers (Topic 606 ). The methodology used is based on contract type and how products and services are provided. The guidelines of Topic 606 establish a five -step process to govern the recognition and reporting of revenue from contracts with customers. The five steps are: (i) identify the contract with

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 6,427 characters as filed

"( 7 ) Stockholders Equity Common Stock On November 22, 2022, the Company filed a third amendment (the Amendment) to the Companys Certificate of Incorporation (as amended, the Certificate of Incorporation) with the Secretary of State of the State of Delaware to effect a 1 -for-30 stock split of all of the Companys issued and outstanding shares of Common Stock. The Amendment provided that, at the effective time of the Reverse Stock Split, every 30 shares of the Companys issued and outstanding Common Stock were automatically combined into one validly issued, fully paid and non-assessable share of Common Stock, without effecting a change to the par value per share. The Reverse Stock Split affected all shares of the Companys Common Stock outstanding immediately prior to the effective time of the Reverse Stock Split, as well as the number of shares of Common Stock available for issuance under the Companys equity incentive plans. In addition, the Reverse Stock Split effected a reduction in the number of shares of Common Stock issuable upon the exercise of stock options and warrants outstanding immediately prior to the effectiveness of the Reverse Stock Split with a corresponding increase in exercise price per share. The Reverse Stock Split also triggered a proportionate adjustment to the number of shares of Common Stock issuable upon the conversion of our Series D convertible preferred stock, par value of $0.001 per share (Series D Preferred Shares). All historical per share data,

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Subsequent events · 119 characters as filed

( 14 ) Subsequent Events Management has determined there are no subsequent events to report through September 26, 2025.

SubsequentEventsTextBlock

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.